News
More evidence MIS-C is a delayed response to SARS-CoV-2
April 13, 2021
CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”
News
COVID-19’s impact on lupus inpatients examined in study
March 24, 2021
Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a French epidemiologic study.
![1]()
News
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
March 11, 2021
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
News
RECOVERY trial of COVID-19 treatments stops colchicine arm
March 8, 2021
Recruitment was halted for lack of efficacy in patients hospitalized with the disease.
![1]()
News
Neurologic disorders ubiquitous and rising in the U.S.
March 2, 2021
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level or declining, offering hope that prevention measures may be having an effect.
![1]()
News
ColCORONA: More questions than answers for colchicine in COVID-19
February 11, 2021
Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer review.
![1]()
News
Rheumatologic disease activity an important influencer of COVID-19 death risk
February 5, 2021
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVID-19.
![1]()
News
COVID-19: Another study links colchicine to better results
February 4, 2021
Brazilian trial tested gout drug against placebo in hospitalized patients.
News
ColCORONA: Colchicine reduces complications in outpatient COVID-19
January 25, 2021
The use of colchicine was reported to significantly reduce hospitalizations, the need for mechanical ventilation, and deaths.
![1]()
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
